Search by Drug Name or NDC

    NDC 64980-0405-24 Abacavir 20 mg/mL Details

    Abacavir 20 mg/mL

    Abacavir is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is ABACAVIR SULFATE.

    Product Information

    NDC 64980-0405
    Product ID 64980-405_b8611a41-39f7-47d1-98ff-e895dbbb18a9
    Associated GPIs 12105005102020
    GCN Sequence Number 040965
    GCN Sequence Number Description abacavir sulfate SOLUTION 20 MG/ML ORAL
    HIC3 W5J
    HIC3 Description ANTIVIRALS, HIV-SPECIFIC, NUCLEOSIDE ANALOG, RTI
    GCN 94678
    HICL Sequence Number 018857
    HICL Sequence Number Description ABACAVIR SULFATE
    Brand/Generic Generic
    Proprietary Name Abacavir
    Proprietary Name Suffix n/a
    Non-Proprietary Name Abacavir Sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name ABACAVIR SULFATE
    Labeler Name Rising Pharmaceuticals, Inc.
    Pharmaceutical Class Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077950
    Listing Certified Through 2024-12-31

    Package

    NDC 64980-0405-24 (64980040524)

    NDC Package Code 64980-405-24
    Billing NDC 64980040524
    Package 1 BOTTLE in 1 CARTON (64980-405-24) / 240 mL in 1 BOTTLE
    Marketing Start Date 2018-03-14
    NDC Exclude Flag N
    Pricing Information N/A